Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
MRSNCompany Name
MERSANA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQMERSANA THERAPEUTICS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MRSN - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ -53.15M | $ 33.99M | 0 |
| 3/31/2025 | $ -30.87M | $ 39.19M | 0 |
| 12/31/2024 | $ -9.51M | $ 59.82M | 0 |
| 9/30/2024 | $ 1.05M | $ 324.89M | 309.72 |
| 6/30/2024 | $ 8.43M | $ 165.61M | 19.65 |
| 3/31/2024 | $ 27.98M | $ 301.62M | 10.78 |
| 12/31/2023 | $ 36.9M | $ 588.32M | 15.94 |
| 9/30/2023 | $ 52.2M | $ 161.58M | 3.1 |
| 6/30/2023 | $ 89.8M | $ 148.22M | 1.65 |
| 3/31/2023 | $ 64.29M | $ 915.09M | 14.23 |
Key Performance Insights, Last 5 Years
- MERSANA THERAPEUTICS INC's latest trailing twelve months (TTM) P/B stands at 6.2.
- Over the past 5 years, MERSANA THERAPEUTICS INC's average P/B has been 24.97.
- The median P/B for MERSANA THERAPEUTICS INC during this period was 5.5
- MERSANA THERAPEUTICS INC reached its highest P/B over the past 5 years at 309.72.
- The lowest P/B recorded by MERSANA THERAPEUTICS INC in the same timeframe 1.65
MERSANA THERAPEUTICS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for MERSANA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 1.57B ] / Equity [ $ 253.31M ]
(=) P/B [ 6.2 ] MRSN - Price to Book, Last 5 years
1.65
Minimum
Jun 30, 2023
309.72
Maximum
Sep 30, 2024
24.97
Average
5.5
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |